Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three Alternative Regimens for Malaria Seasonal Intermittent Preventive Treatment in Senegal
NCT00529620Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2007
- Primary completion
- Dec 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in malaria comparing sulfalene pyrimethamine plus amodiaquine, dihydroartemisinin piperaquine and sulfadoxine-pyrimethamine plus piperaquine (3 arms). Primary endpoint: Incidence of malaria at 4 months. Started Sep 2007; status: completed.
02
Drugs
sulfadoxine + pyrimethamineamodiaquinedihydroartemisininpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00529620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529620.